IDSA Home

What's New

Ivermectin and COVID-19: Legal Intervention in Clinical Practice Exposes Patients to Serious Harm

Clinicians, scientists and public health leaders on the front lines of our response to the COVID-19 pandemic remain eager for new safe and effective therapies to treat the disease. The suffering and loss of life due to COVID-19 are tragic. We empathize with patients and their loved ones and are working to ensure the best care and outcomes for all.

IDSA Guidelines on the Treatment and Management of Patients with COVID-19

Summarized in this clinical practice guideline are the recommendations for the treatment and management of patients with COVID-19. On February 22, IDSA released a special update alert containing two new recommendations on the use of lopinavir/ritonavir in persons exposed to or with COVID-19.

weg

wegwgwegwegwegewg

Register for Free Member Webinar Focused on ID Compensation Conversations:

Join Mark Call, MD, and Amy Strauss of ECG Management Consultants, an industry leader in structuring value-based compensation arrangements, on Feb. 23 at 5 p.m. ET as they discuss the meaning of value-based care and explore the opportunities created by market changes to incorporate value-based arrangements into infectious disease. Register now (member login required).

IDSA Journals Launch Call for Associate Editor Applications

IDSA’s journals, Clinical Infectious Diseases, The Journal of Infectious Diseases and Open Forum Infectious Diseases, are launching a call for applications for all qualified individuals with interest in joining the journals as associate editors.

Infectious Diseases Society of America Announces Next Editor-in-Chief of Clinical Infectious Diseases

IDSA is pleased to announce that Paul E. Sax, MD, FIDSA, has been selected as the next editor-in-chief of Clinical Infectious Diseases. Dr. Sax will succeed Robert T. Schooley, MD, on July 1, 2022, following Dr. Schooley’s years of outstanding service to the journal and the Society.

Syndromic Testing for Gastroenteritis: Improving Patient Care

This educational activity, in partnership with Medscape, will improve the ability of clinicians to implement syndromic testing in the diagnosis and management of gastroenteritis. Faculty include Ferric C Fang, MD and William Greendyke, MD. A maximum of 0.25 AMA PRA Category 1 Credit(s)™ and a maximum of 0.25 ABIM MOC points. Begin the activity. (Login Required)